Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Intezyne Technologies Inc.
DescriptionDoxorubicin formulation using INVECT technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today